Fever-range whole body hyperthermia increases the number of perfused tumor blood vessels and therapeutic efficacy of liposomally encapsulated doxorubicin

References

• van der Zee J, González González D, van Rhoon GC, van Dijk JDP, van Putten WLJ, Hart AAM. Comparision of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumors: A prospective, randomized, multicentre trial–Dutch Deep Hyperthermia Group. Lancet 2000; 355: 1119–1125
   PubMed Web of Science ®Google Scholar
• Harima Y, Nagata K, Harima K, Ostapenko VV, Tanaka Y, Sawada S. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int J Hyperthermia 2001; 17: 97–105
   PubMed Web of Science ®Google Scholar
• Sharma S, Sandhu AP, Patel FD, Ghoshal S, Gupta BD, Yadav NS. Side-effects of local hyperthermia: Results of a prospectively randomized clinical study. Int J Hyperthermia 1990; 6: 279–285
   PubMed Web of Science ®Google Scholar
• Sneed PK, Stauffer PR, McDermott MW, Diederich CJ, Lamborn KR, Prados MD, Chang S, Weaver KA, Spry L, Malec MK, Lamb SA, Voss B, Davis RL, Wara WM, Larson DA, Phillips TL, Gutin PH. Survival benefit of hyperthermia in a prospectively randomized trial of brachythermy boost +/− hyperthermia for glioblastoma multiforme. J Radiat Oncol Biol Phys 1998; 40: 287–295
   PubMed Web of Science ®Google Scholar
• Jones EL, Oleson JR, Prosnitz LR, Samulski TV, Vujaskovic Z, Yu D, Sanders LL, Dewhirst MW. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 2005; 23: 3079–3085
   PubMed Web of Science ®Google Scholar
• Thrall DE, Prescoot DM, Samulski TV, Rosner GL, Denman DL, Legorreta RL, Dodge RK, Page RL, Cline JM, Case BC, Evans SM, Oleson JR, Dewhirst MW. Radiation plus local hyperthermia and whole-body hyperthermia in canine sarcomas. Int J Oncol Biol Phys 1996; 34: 1087–1096
   PubMed Web of Science ®Google Scholar
• Falk MH, Issels RD. Invited review: Hyperthermia in oncology. Int J Hyperthermia 2001; 17: 1–18
   PubMed Web of Science ®Google Scholar
• Corry PM, Armour EP. The heat shock response: Role in radiation and cancer therapy. Int J Hyperthermia 2005; 21: 769–778
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Vujaskovic Z, Jones E, Thrall D. Re-setting the biologic rationale for thermal therapy. Int J Hyperthermia 2005; 21: 779–790
   PubMed Web of Science ®Google Scholar
• Brady TJ, Gerweck LE. Relationship of changes in pH and energy status to hypoxic cell fraction and hyperthermia sensitivity. Int J Radiat Oncol Biol Phys 1990; 18: 1429–1435
   PubMedGoogle Scholar
• Engin K, Leeper DB, Thistlethwaite AJ, Tupchong L, McFarlane JD. Tumor extracellular pH as a prognostic factor in thermoradiotherapy. Int J Radiat Oncol Biol Phys 1994; 29: 125–132
   PubMed Web of Science ®Google Scholar
• Reinhold HS, Endrich B. Tumor microcirculation as a target for hyperthermia. Int J Hyperthermia 1986; 2: 111–137
   PubMedGoogle Scholar
• Song CW. Effect of local hyperthermia on blood flow and microenvironment: A review. Cancer Res 1984; 44: 4721s–4730s
   PubMed Web of Science ®Google Scholar
• Horsman MR, Overgaard J. Can mild hyperthermia improve oxygenation?. Int J Hyperthermia 1997; 13: 141–147
   PubMed Web of Science ®Google Scholar
• Endrich B, Vaupel P. The role of microcirculation in the treatment of malignant tumors: Facts and fiction. Blood perfusion and Microenvironment of Human Tumors: Implications for Clinical Radiooncology, M Molls, P Vaupel. Springer Verlag, Berlin 2000; 19–40, (Brady LW, Heilmann H-P, Molls M, Series editors. Medical Radiology: Radiation Oncology)
   Google Scholar
• Song CW, Park HJ, Lee CK, Griffin R. Implication of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment. Int J Hyperthermia 2005; 21: 761–767
   PubMed Web of Science ®Google Scholar
• Shakil A, Osborn JL, Song CW. Changes in oxygenation status and blood flow in a rat tumor model by mild temperature hyperthermia. Int J Rad Oncol Biol Phys 1999; 43: 859–865
   PubMed Web of Science ®Google Scholar
• Thrall DE, Larue SM, Pruitt AF, Case B, Dewhirst MW. Changes in tumor oxygenation during fractionated hyperthermia and radiation therapy in spontaneous canine sarcomas. Int J Hyperthermia 2006; 22: 365–373
   PubMed Web of Science ®Google Scholar
• Kong G, Dewhirst MW. Hyperthermia and liposomes. Int J Hyperthermia 1999; 15: 345–370
   PubMed Web of Science ®Google Scholar
• Kong G, Anyarambhatia G, Petros WP, Braun RD, Colvin OM, Needham D, Dewhirst MW. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: Importance of triggered drug release. Cancer Res 2000; 60: 6950–6957
   PubMed Web of Science ®Google Scholar
• Kong G, Braun RD, Dewhirst MW. Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. Cancer Res 2001; 61: 3027–3032
   PubMed Web of Science ®Google Scholar
• Ohtsubo T, Igawa H, Saito T, Matsumoto H, Park H, Song CW, Kano E, Saito H. Enhancement of cell killing by induction of apoptosis after treatment with mild hyperthermia at 42°C and cisplatin. Radiation Res 2001; 156: 103–109
   PubMedGoogle Scholar
• Kouloulias VE, Dardoufas CF, Kouvaris JR, Gennatas CS, Polyzos AK, Gogas HJ, Sandilos PH, Uzunoglu NK, Malas EG, Vlahos LJ. Liposomal doxorubicin in conjunction with reirradiation and local hyperthermia treatment in recurrent breast cancer: A Phase I/II trial. Clin Cancer Res 2002; 8: 374–382
   PubMed Web of Science ®Google Scholar
• Jones EL, Samulski TV, Dewhirst MW, Alvarez-Secord A, Berchuck A, Clarke-Pearson D, Havrilesky LJ, Soper J, Prosnitz LR. A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma. Cancer 2003; 98: 277–282
   PubMed Web of Science ®Google Scholar
• Jones EL, Prosnitz LR, Dewhirst MW, Marcom PK, Hardenbergh PH, Marks LB, Brizel DM, Vujaskovic Z. Thermochemoradiotherapy improves oxygenation in locally advanced breast cancer. Clin. Cancer Res 2004; 10: 4287–4293
   PubMed Web of Science ®Google Scholar
• Alvarez Secord A, Jones EL, Hahn CA, Petros WP, Yu D, Havrilesky LJ, Soper JT, Berchuck A, Spasojevic I, Clarke-Pearson DL, Prosnitz LR, Dewhirst MW. Phase I/II trial of intravenous DOXIL and whole abdomen hyperthermia in patients with refractory ovarian cancer. Int J Hyperthermia 2005; 21: 333–347
   PubMed Web of Science ®Google Scholar
• Hahn CA, Jones EL, Blivin JL, Sanders LL, Yu D, Dewhirst MW, Alverez-Secord A, Prosnitz LR. Prospective assessment of quality of life in ovarian cancer patients receiving whole abdomen hyperthermia and liposomal doxorubicin. Int J Hyperthermia 2005; 21: 349–357
   PubMed Web of Science ®Google Scholar
• Westermann AM, Jones EL, Schem BC, van der Steen-Banasik EM, Koper P, Mella O, Uitterhoeve AL, de Wit R, van der Velden J, Burger C, et al. First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma. Cancer 2005; 104: 763–770
   PubMed Web of Science ®Google Scholar
• Rowe-Horwege RW. Hyperthermia, systemic encyclopedia of medical devices and instrumentation, JG Webster. John Wiley and Sons, Inc. 2006
   Google Scholar
• Bull JM, Cronau LH, Newman BM, Jabboury K, Allen SJ, Ohno S, Smith T, Tonnesen A.S. Chemotherapy resistant sarcoma treated with whole body hyperthermia (WBH) combined with 1-2-bis(2-chloroethyl)-1-nitrosourea (BCNU). Int J Hyperthermia 1992; 8: 297–304
   PubMed Web of Science ®Google Scholar
• Robins HI, Cohen JD, Schmitt CL, Tutsch KD, Feierabend C, Arzoomanian RZ, Alberti D, D’Oleire F, Longon W, Heiss C, et al. Phase I clinical trial of carboplatin at 41.8°C whole-body hyperthermia in cancer patients. J Clin Oncol 1993; 11: 1787–1794
   PubMed Web of Science ®Google Scholar
• Ohno S, Strebel FR, Stephens LC, Siddik ZH, Baba H, Makino M, Khokhar AR, Bull JM. Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats. Brit J Cancer 1993; 68: 469–474
   PubMed Web of Science ®Google Scholar
• Sakaguchi Y, Makino M, Kaneko T, Stephens LC, Strebel FR, Danhauser LL, Jenkins GN, Bull JM. Therapeutic efficacy of long duration-low temperature whole body hyperthermia when combined with tumor necrosis factor and carboplatin in rats. Cancer Res 1994; 54: 2223–2227
   PubMed Web of Science ®Google Scholar
• Matsuda H, Strebel FR, Kaneko T, Danhauser LL, Jenkins GN, Toyota N, Bull JM. Long duration mild whole-body hyperthermia of up to 12 hours in rats: Feasibility, and efficacy on primary tumour and axillary lymph node metastases of a mammary adenocarcinoma: Implications for adjuvant therapy. Int J Hyperthermia 1997; 13: 89–98
   PubMed Web of Science ®Google Scholar
• Hughes CS, Repasky EA, Bankert RB, Johnson RJR, Subjeck JR. Effects of hyperthermia on spectrin expression patterns of murine lymphocytes. Rad Res 1987; 112: 116–123
   PubMed Web of Science ®Google Scholar
• Di YP, Repasky ER, Subjeck JR. Distribution of HPS70, protein kinase C, and spectrin is altered in lymphocytes during a fever-like hyperthermia exposure. J Cell Physiol 1997; 172: 44–54
   PubMed Web of Science ®Google Scholar
• Burd R, Dziedzic TS, Xu Y, Caligiuri MA, Subjeck JA, Repasky EA. Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia. J Cell Physiol 1998; 177: 137–147
   PubMed Web of Science ®Google Scholar
• Repasky EA, Tims E, Prichard M, Burd R. Characterization of mild whole-body hyperthermia protocols using human breast, ovarian, and colon tumors grown in severe combined immunodeficient mice. Infect Dis Obstet Gynecol 1999; 7: 91–97
   PubMedGoogle Scholar
• Ostberg JR, Ertel BR, Lanphere JA. An important role for granulocytes in the thermal regulation of colon tumor growth. Immunol Invest 2005; 34: 259–272
   PubMed Web of Science ®Google Scholar
• Wang XY, Ostberg JR, Repasky EA. Effect of fever-like whole-body hyperthermia on lymphocyte spectrin distribution, protein kinase C activity, and uropod formation. J Immunol 1999; 162: 3378–3387
   PubMed Web of Science ®Google Scholar
• Ostberg JR, Repasky ER. Comparison of the effects of two different whole body hyperthermia protocols on the distribution of murine leukocyte populations. Int J Hyperthermia 2000; 16: 29–43
   PubMed Web of Science ®Google Scholar
• Ostberg JR, Kaplan KC, Repasky ER. Induction of stress proteins in a panel of mouse tissue by fever-range whole body hyperthermia. Int J Hyperthermia 2002; 18: 551–562
   Google Scholar
• Pritchard MT, Ostberg JR, Evans SS, Burd R, Kraybill W, Bull JM, Repasky EA. Protocols for simulating the thermal component of fever: Preclinical and clinical experience. Methods 2004; 32: 54–62
   PubMed Web of Science ®Google Scholar
• Wang WC, Goldman LM, Schleider DM, Subjeck JR, Repasky EA, Evans SS. Fever-range hyperthermia enhances L-selectin-dependent adhesion of lymphocytes to vascular endothelium. J Immunol 1998; 160: 961–969
   PubMed Web of Science ®Google Scholar
• Evans SS, Bain D, Wang WC. Fever-range hyperthermia stimulates α4B7 integrin-dependent lymphocyte-endothelial adhesion. Int J Hyperthermia 2000; 16: 45–59
   PubMed Web of Science ®Google Scholar
• Evans SS, Wang WC, Bain MD, Burd R, Ostberg JR, Repasky EA. Fever-range hyperthermia dynamically regulates lymphocyte delivery to high endothelial venules. Blood 2001; 97: 2727–2733
   PubMed Web of Science ®Google Scholar
• Chen Q, Fisher DT, Clancy KA, Gauguet JM, Wang WC, Unger E, Rose-John S, von Adrian UH, Baumann H, Evans SS. Fever-range hyperthermia promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanim. Nat Immunol 2006; 7: 1299–1308
   PubMed Web of Science ®Google Scholar
• Ostberg JR, Taylor SL, Baumann H, Repasky EA. Regulatory effects of fever-range whole body hyperthermia on the LPS-induced acute inflammatory response. J Leuk Biol 2000; 68: 815–820
   PubMed Web of Science ®Google Scholar
• Ostberg JR, Gellin C, Patel R, Repasky ER. Regulatory potential of fever-range whole body hyperthermia on Langerhans cells and lymphocytes in an antigen-dependant cellular immune response. J Immunol 2001; 167: 2666–2670
   PubMed Web of Science ®Google Scholar
• Ostberg JM, Repasky EA. Emerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function. Cancer Immunol Immuntherapy 2006; 55: 92–95
   Google Scholar
• Ostberg JR, Dayanc BE, Yuan M, Oflazoglu E, Repasky ER. Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent upon NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells. J Leukoc Biol 2007. 82, (In Press)
   Google Scholar
• Naka T, Hylander BL, Rustum YM, Widmer MB, Repasky EA. Effects of tumor necrosis factor-related Apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients’ colon tumors grow in SCID mice. Cancer Res 2002; 62: 5800–5806
   PubMed Web of Science ®Google Scholar
• Trotter MJ, Chaplin DJ, Olive PL. Use of carbocyanine dye as a maker of functional vasculature in murine tumours. Brit J Cancer 1989; 59: 706–709
   PubMedGoogle Scholar
• Robert J. Extraction of anthrocyclins from biological fluids for HPLC evaluation. Clin Pharm Ther 1980; 22: 234–252
   Google Scholar
• Guyton AC, Hall JE. Body temperature, temperature regulation, and fever, AC Guyton, JE Hall. Elsevier, Philadelphia, PA 2006; 889–901
   Google Scholar
• Boulant JA. Hypothalamic neurons. Mechanisms of sensitivity to temperature. Ann NY Acad Sci 1998; 856: 108
   PubMedGoogle Scholar
• Romanowsky AA. Thermoregulation: Some concepts have changed. Functional architecture of the thermoregulatory system. Am J Physiol Regul Integr Comp Research 2007; 292: R37–R46
   Web of Science ®Google Scholar
• Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nature Rev Cancer 2006; 6: 583–592
   PubMed Web of Science ®Google Scholar
• Dvorak HF. How tumors make bad blood vessels. Amer Soc Invest Path 2003; 162: 1747–1557
   Google Scholar
• Jain RK. Barriers to drug delivery in solid tumors. Scientific American 1994; 271: 58–65
   PubMed Web of Science ®Google Scholar
• Gabizon A, Shiota R, Papahadjopoulos D. Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times. J Natl Cancer Inst 1989; 81: 1484–1488
   PubMed Web of Science ®Google Scholar
• Gabizon A, Martin F. Polyethylene glycol-coated (pegylated) liposomal doxorubicin: Rationale for use in solid tumors. Drugs 1997; 54(Suppl 4)15–21
   PubMed Web of Science ®Google Scholar
• Huang SK, Stauffer PR, Hong K, Guo JWH, Phillips TL, Huang A, Papahadjopoulos D. Liposomes and hyperthermia in mice: Increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. Cancer Res 1994; 54: 2186–2191
   PubMed Web of Science ®Google Scholar
• Vaage J, Barbera-Guillem E, Abra R, Huang A, Working P. Tissue distribution and therapeutic effect of intravenous free or encapsulated liposomal doxorubicin on human prostate carcinoma xenografts. Cancer 1994; 73: 1478–1484
   PubMed Web of Science ®Google Scholar
• Vaage J, Donovan D, Loftus T, Working P. Tumor uptake of doxorubicin in polyethylene glycol-coated liposomes and therapeutic effect against a xenografted human pancreatic carcinoma. Brit J Cancer 1997; 75: 482–486
   PubMed Web of Science ®Google Scholar
• Ranson M, Carmichael J, O’Bryne K, Stewart S, Smith D, Howell A. Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial. J Clin Oncol 1997; 15: 3185–3191
   PubMed Web of Science ®Google Scholar